Literature DB >> 2249326

A new intraperitoneal tumor model in the rat.

J D Nagel1, G Los, A C Begg, J G McVie.   

Abstract

A new tumour model that is particularly suitable for testing intraperitoneal chemotherapy is described. Single tumours were induced to grow in the mesentery of rats by the implantation of small pieces taken from subcutaneous tumours. Tumour growth was monitored by repeated laparotomies at which the tumour size was measured with calipers. In this way, growth curves of treated and untreated tumours could be defined. The diameter of untreated intraperitoneal tumours increased linearly with time [diameter (mm) = 0.39 t (days) +2.4]. Tests using different numbers of laparotomies showed that the procedure itself had little influence on growth. Cell kinetic studies of 6-mm tumours showed a mean labelling index of 31% and a volume-doubling time of 3.9 days, resulting in cell-loss factors probably in excess of 70%. The model was tested by assessing the effect of the chemotherapeutic agent cisplatin. Regression and regrowth could be satisfactorily followed, leading to estimates of growth delay. This model therefore provides a quantitative way to assess the response of intraperitoneal tumours to chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2249326     DOI: 10.1007/bf00689095

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  7 in total

1.  The cellular proliferation kinetics of animal tumors.

Authors:  J Denekamp
Journal:  Cancer Res       Date:  1970-02       Impact factor: 12.701

Review 2.  Intraperitoneal chemotherapy: a review.

Authors:  D E Brenner
Journal:  J Clin Oncol       Date:  1986-07       Impact factor: 44.544

3.  Experimental and clinical results with intraperitoneal cisplatin.

Authors:  W W ten Bokkel Huinink; R Dubbelman; E Aartsen; H Franklin; J G McVie
Journal:  Semin Oncol       Date:  1985-09       Impact factor: 4.929

4.  Human tumour cell kinetics using a monoclonal antibody against iododeoxyuridine: intratumour sampling variations.

Authors:  A C Begg; L Moonen; I Hofland; M Dessing; H Bartelink
Journal:  Radiother Oncol       Date:  1988-04       Impact factor: 6.280

5.  Characterization of a xenograft model of human ovarian carcinoma which produces ascites and intraabdominal carcinomatosis in mice.

Authors:  T C Hamilton; R C Young; K G Louie; B C Behrens; W M McKoy; K R Grotzinger; R F Ozols
Journal:  Cancer Res       Date:  1984-11       Impact factor: 12.701

6.  Interferon treatment of a transplantable rat colon adenocarcinoma: importance of tumor site.

Authors:  R L Marquet; D L Westbroek; J Jeekel
Journal:  Int J Cancer       Date:  1984-05-15       Impact factor: 7.396

7.  The gross response of an experimental tumour to single doses of x-rays.

Authors:  R H Thomlinson; E A Craddock
Journal:  Br J Cancer       Date:  1967-03       Impact factor: 7.640

  7 in total
  3 in total

1.  A new liver-tumor model in the rat.

Authors:  J D Nagel; W J Kort
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 2.  Platinum antitumour agents: a review of (bio)analysis.

Authors:  T J Hodes; W J Underberg; G Los; J H Beijnen
Journal:  Pharm Weekbl Sci       Date:  1992-06-19

3.  Intraperitoneal photodynamic therapy of the rat CC531 adenocarcinoma.

Authors:  R B Veenhuizen; J P Marijnissen; P Kenemans; M C Ruevekamp-Helmers; L W 't Mannetje; T J Helmerhorst; F A Stewart
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.